Exact Mass: 368.1963

Exact Mass Matches: 368.1963

Found 14 metabolites which its exact mass value is equals to given mass value 368.1963, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

LysoPA(a-13:0/0:0)

{2-hydroxy-3-[(10-methyldodecanoyl)oxy]propoxy}phosphonic acid

C16H33O7P (368.1964)


LysoPA(a-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(a-13:0/0:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

   

LysoPA(i-13:0/0:0)

{2-hydroxy-3-[(11-methyldodecanoyl)oxy]propoxy}phosphonic acid

C16H33O7P (368.1964)


LysoPA(i-13:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-13:0/0:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

   

(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol

(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol

C19H24N6O2 (368.1961)


   

PA(13:0/0:0)

[(2R)-2-hydroxy-3-phosphonooxypropyl] tridecanoate

C16H33O7P (368.1964)


   

LPA 13:0

1-tridecanoyl-sn-glycero-3-phosphate

C16H33O7P (368.1964)


   

trans,trans-3,4,5-trifluorophenyl 4-ethylbicyclohexyl-4-carboxylate

trans,trans-3,4,5-trifluorophenyl 4-ethylbicyclohexyl-4-carboxylate

C21H27F3O2 (368.1963)


   
   

BMS-690514

(3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol

C19H24N6O2 (368.1961)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   

4-Amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol

4-Amino-1-((4-(3-methoxyphenylamino)pyrrolo[1,2-f][1,2,4]triazin-5-yl)methyl)piperidin-3-ol

C19H24N6O2 (368.1961)


   

4-[(E)-{2-[2,6-di(pyrrolidin-1-yl)pyrimidin-4-yl]hydrazinylidene}methyl]benzene-1,2-diol

4-[(E)-{2-[2,6-di(pyrrolidin-1-yl)pyrimidin-4-yl]hydrazinylidene}methyl]benzene-1,2-diol

C19H24N6O2 (368.1961)


   

(2-Hydroxy-3-phosphonooxypropyl) tridecanoate

(2-Hydroxy-3-phosphonooxypropyl) tridecanoate

C16H33O7P (368.1964)


   

1-tridecanoyl-sn-glycero-3-phosphate

1-tridecanoyl-sn-glycero-3-phosphate

C16H33O7P (368.1964)